Investor directory

OncoCyte

OncoCyte is a biotechnology company that focuses on the discovery, development, and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer. The company's mission is to provide actionable answers to physicians and patients at critical decision points along the lung cancer care continuum, to optimize diagnosis and treatment, improve patient outcomes, and reduce the overall cost of care. OncoCyte was established in 2009 and is based in Alameda, California.

Top Stages

Acquisition
http://www.oncocyte.com
https://crunchbase.com/organization/oncocyte
https://facebook.com/oncocyte
https://linkedin.com/company/oncocyte-corporation
https://twitter.com/oncocytelbx
https://www.capitaliq.com/CIQDotNet/company.aspx?companyId=78474527

Andrea James

CFO, Finance

1 past transactions

Chronix Biomedical

Acquisition in 2021
Chronix Biomedical is pioneering a breakthrough approach to the diagnosis and management of chronic diseases and cancer. It has developed proprietary technology that measures and categorizes circulating nucleic acids, DNA sequences circulating in the blood that are associated with specific changes in disease and health status. Chronix plans to collaborate with a variety of partners to develop and market its DNA-based assays that have the potential to transform the management of a broad range of cancers and other conditions. Chronix is headquartered in San Jose, California and has research facilities in Germany.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.